Cell and gene therapy at FoG London 2027
Jan 27–28, 2027 London, UK ~8.3k attendees Website
18 organizations at FoG London 2027 present work in cell & gene therapy: 7 drug and crop developers, 6 NHS, government and non-profit bodies, 3 universities and research institutes and 2 suppliers and service providers. Between them they bring 53 presentations to the program. Most represented: University of Oxford, UCL and MHRA. As of Oct 29, 2026.
Format
Top represented
Showing 1–7 of 18 organizations
| Organization | FoG London 2027 Attendance |
|---|---|
University of Oxford Oxford, UK | |
Collegiate research university in Oxford, England, whose Medical Sciences Division spans human genetics, population health and clinical research. | Talk Wed Jan 27 11:30–12:00 Why Do We Sleep? Why animals evolved to sleep, how light and body clocks time it, and how shift work and jet lag disrupt health. Population & social genomics Talk Wed Jan 27 12:30–13:00 Sequence Data for Outbreak Intelligence: Gene-by-Gene Genomics and Population Annotation in Pathogen Surveillance Why tracking bacterial outbreaks needs gene-by-gene genome comparison rather than human genetics methods, shown through an outbreak of meningococcal disease in Kent. Talk Wed Jan 27 14:30–15:00 Design and Translation of Next Generation Delivery Vehicles for Advanced Therapeutics New ways to deliver advanced therapies, including pulsed and long-acting release systems, microrobots and new tools for measuring nanoparticles. Talk Wed Jan 27 14:30–15:00 Making AMR Diagnostics Work Where They Matter Most: Genomics, Sepsis and Sustainable Implementation Why tests for drug-resistant infections and newborn sepsis in low- and middle-income countries depend on cost and infrastructure, and how genomics tracks spread. Talk Wed Jan 27 16:30–17:00 Accelerating the Development of Therapies for Rare Genetic Disease How a transatlantic partnership brings expertise and investment to preclinical drug projects for rare genetic diseases. Talk Wed Jan 27 16:30–17:00 The AI Revolution After the Genome: How AI Is Inventing Genetically Enabled Medicines How genomic discoveries, national supercomputers and self-running laboratories are letting AI design new medicines based on genetics. Talk Wed Jan 27 16:30–17:00 The Body Clock in Your Blood: Circadian Signals in Omics Research How proteins and metabolites in one blood sample can reveal a person's body-clock time, and why time of day skews biomarker studies. Talk Wed Jan 27 17:30–18:00 Using Pathogen Genomics to Inform Vaccine Strategy and Public Health Response How international lab data on invasive bacterial disease track post-pandemic shifts in bacterial strains and what they mean for vaccines. Talk Thu Jan 28 11:30–12:00 Harnessing Bacterial Competition to Prevent Disease in the Gut Microbiome How finding the gut bacteria that best outcompete pathogens can guide the design of protective microbial mixtures. Talk Thu Jan 28 12:30–13:00 Deciphering Mammalian Morphogenesis - A Single-Cell Phenomic Perspective How tracking single cells' molecules, shape and behaviour in early mammalian embryos shows how the front end is patterned and the heart starts beating. Panel Thu Jan 28 14:10–14:40 Is Modern Life Fighting Our Human Biology? Whether modern food environments and inactive lifestyles clash with our evolved biology, and why genetics makes some people more prone to obesity. Population & social genomics Talk Thu Jan 28 14:10–14:40 Multimodal Liquid Biopsy for Early Cancer Detection: From Methylation to Single-Molecule Sequencing Why first-generation multi-cancer blood tests fall short, and how AI analysis of several features of tumour DNA in the blood could improve them. Talk Thu Jan 28 14:10–14:40 Quantum Computing & The Future of Genomic Data: From Single Genomes to Pangenomes How a virus genome encoded on a quantum computer points to new ways of analysing pangenomes, reference sets built from many genomes. Talk Thu Jan 28 14:10–14:40 Why Endometriosis Is Not One Disease: Insights from Genetics How large genetic studies split endometriosis into distinct subtypes, link it to ovarian and endometrial cancers and point to new treatment targets. Workshop Thu Jan 28 14:10–15:40 Making Sense of Multi-Omic Data: Scalable Analysis and Interpretation Multi-omics & proteomics Talk Thu Jan 28 14:40–15:10 Talk Thu Jan 28 15:10–15:40 Utilising Multi-omic Integration & Machine Learning for the Better Understanding of Disease: Painful and Painless Peripheral Neuropathy Example How combining genetic, gene expression, protein and metabolite markers could explain why only some people with nerve damage develop lasting pain. Panel Thu Jan 28 15:10–15:40 Why Does Disease Spare Some of Us? Why the same infection makes some people very ill and spares others, and how naturally resistant people could inspire new treatments. Population & social genomics Talk Thu Jan 28 16:10–16:40 Single-Cell & Spatial Multi-Omics to Decrypt Intestinal Development How a cell-by-cell map of the developing human gut tracks its maturation and why preterm birth may impair it. Workshop Thu Jan 28 16:10–17:10 From Variant to Action: A Hands-On Workshop to Reimagine Variant Interpretation Genomic medicine & rare disease Talk Thu Jan 28 16:40–17:10 Human in vivo Perturb Seq: New Insights into Human Inflammatory Disease How repeated tissue biopsies from treated patients, read cell by cell, reveal how drugs act on inflammatory diseases and why some stop working. Talk Thu Jan 28 16:40–17:10 Leveraging Big Data to Inform Cardiovascular Precision Medicine How combining genomic, clinical and real-world patient data can identify cardiovascular disease risk and guide more targeted prevention and treatment. |
UCL London, UK | |
Multidisciplinary London research university with faculties of medical, life, brain and population health sciences, including the Great Ormond Street Institute of Child Health. | Talk Wed Jan 27 11:30–12:00 What Do We Need to Get More Advanced Therapies to Patients? How regulatory changes in the US, UK and EU, plus practical rollout models, could bring more advanced therapies to patients. Talk Wed Jan 27 12:30–13:00 Quantitative Proteomics to Unravel Signaling in Rare Cells How mapping protein phosphorylation in just hundreds of cells reveals dormant, drug-resistant glioblastoma cells and leftover disease in acute myeloid leukaemia. Talk Wed Jan 27 14:30–15:00 Resolving RNA Diversity in Neurodegenerative Disease: From Mechanism to Therapeutic Targeting How large human brain RNA datasets link disease-associated genetic variants to genes and mechanisms in Lewy body disorders and related neurodegenerative diseases. Talk Wed Jan 27 15:30–16:00 Tracing Metastatic Evolution with Spatial Biology: Insights for Immunity and Immune Evasion How mapping cells in place across primary tumours and their metastases reveals the earliest steps of cancer spread and immune escape. Talk Wed Jan 27 15:30–16:00 Why Does the Food Environment Affect Us Differently? What it means to call obesity genetic, how genes and food surroundings interact to shape weight, and what a twin study shows. Population & social genomics Talk Wed Jan 27 16:30–17:00 Personalised Surveillance in Ovarian Cancer: Does It Work? Whether tracking a blood tumour marker over time helps women at high genetic risk of ovarian cancer who are awaiting preventive surgery. Talk Wed Jan 27 16:30–17:00 Why Do We Age So DIfferently? Why people with similar genes and lifestyles age at different rates, and what genetically identical organisms reveal about chance in ageing. Population & social genomics Talk Thu Jan 28 10:30–11:00 Who Do We Think We Are? What the Last Decade of Genomics Has Revealed About Us What ancient DNA has revealed about human migration and ancestry, and what genetics can and cannot say about race and identity. Population & social genomics Talk Thu Jan 28 11:30–12:00 Ageing as a Modifiable Process: From Lifestyle to Therapeutic Intervention How exercise, sleep, diet and social life shape ageing, and whether existing drugs could target ageing biology to delay disease. Talk Thu Jan 28 11:30–12:00 Talk Thu Jan 28 12:30–13:00 Rewriting the Rules: Gene Therapy and Clinical Trials in Pregnancy Why pregnant women were long excluded from clinical trials, how pregnancy research can now run safely, and what fetal gene therapy could offer. Panel Thu Jan 28 14:40–15:10 What Will Human Evolution Look Like Next? Evidence that humans are still evolving, and how disease, climate, migration and gene editing could shape where evolution goes next. Population & social genomics Talk Thu Jan 28 16:10–16:40 25 Years of Gene Therapy for Inherited Immune Disorders: Progress and Future Potential How gene and cell therapies are moving from experiments toward potential cures for inherited blood diseases and cancer, and what blocks wider access. Talk Thu Jan 28 16:10–16:40 Critical Appraisal of Polygenic Risk Scores and Circulating Proteins for Screening, Risk Stratification and Individual Risk Prediction How to judge whether polygenic risk scores and blood protein markers really help with screening, risk grouping and predicting individual disease risk. Talk Thu Jan 28 16:40–17:10 From Research to Reality: Ensuring Women Benefit from Innovation How to design women's health tests and technologies that work for all women, and who risks being left behind by them. |
M MHRA London, UK | |
UK regulator of medicines and medical devices, including clinical trial and marketing approvals for advanced therapies. | Talk Thu Jan 28 14:10–14:40 De-risking ATMP Innovation & Streamlining Pathways to Deliver Better Outcomes for Patients How advanced cell and gene therapies could reach patients sooner through smarter trials, a new law allowing on-site manufacturing, and fairer research. Talk Thu Jan 28 16:40–17:10 Navigating MHRA Guidelines and Clinical Trial Regulations for ATMPs How to apply to the UK medicines regulator for a clinical trial of an advanced cell or gene therapy, with practical tips. |
NHS Wales body advising on access to medicines, their safe and effective use, and poisons information. | Talk Thu Jan 28 11:30–12:00 Building System Readiness for Disruptive Medicines in Wales How Wales is preparing its health service for new precision medicines, planning 6–12 months before national approval guidance to meet a 60-day access target. |
Cell and Gene Therapy Catapult London, UK | |
Independent UK innovation and technology organisation supporting the development, manufacture and adoption of cell and gene therapies. | Booth Exhibiting at Booth 15 Talk Thu Jan 28 12:30–13:00 The Acceleration of Therapies from Diagnosis to Delivery How genomic diagnosis is opening the way to personalised treatments, and what UK treatment centres have learned about getting advanced therapies to patients. |
TTP Melbourn, UK | ◆Agenda Partner |
Technology and product development consultancy near Cambridge; its advanced therapies team helps bring cell and gene therapies to GMP manufacturing. | Panel Wed Jan 27 17:30–18:00 How Can We Bridge the Gap from Discovery to GMP Manufacturing? When and how cell and gene therapy developers should plan manufacturing and regulation so a lab process can scale without losing quality. |
ABPI London, UK | |
Trade association for pharmaceutical companies operating in the UK, working on medicines policy, regulation and patient access. | Panel Wed Jan 27 12:30–13:00 Designing the Next Generation of Rare Disease Therapies: From Advanced Genomics to AI-Enabled Therapeutic Innovation How better knowledge of disease genetics and AI could shape the design of more precise, personalised treatments for rare diseases. |
Find buyers in cell & gene therapy
Tell us what you sell and we’ll find the people at organizations working on cell & gene therapy most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Browse FoG London 2027 by
Organization type
Topic
- Genomic medicine & rare disease 54
- Cancer genomics & diagnostics 31
- AI in drug discovery & diagnostics 43
- Biodata & bioinformatics 33
- Single-cell genomics 24
- Spatial biology 19
- Multi-omics & proteomics 31
- Epigenetics & translational omics 16
- Pharmacogenomics & patient stratification 16
- Women’s and children’s health 13
- Cell & gene therapy 18
- Microbiome & pathogen genomics 17
- Plant & agricultural genomics 13
- Population & social genomics 23
Exhibit hall
Everyone
Not affiliated with or endorsed by Front Line Genomics or the Festival of Genomics. Submit a correction